About this trial
A Randomized, Open Label, Phase III Trial to Evaluate Radical Local Treatment versus Palliative Treatment for Breast Cancer Patients with Primary Ipsilateral Humerus or Sternum Oligometastasis
Eligibility criteria
Qualifiers
Patients provided written informed consent
Women aged 18-75 years old
Histologically confirmed breast cancer and after radical mastectomy
Patients of breast cancer with ipsilateral humerus or sternum oligometastasis, and there is no imaging evidence of other site metastases
Disqualifiers
Without radical mastectomy of the primary breast lesions
No radical resection or radiotherapy is possible for metastatic lesions
Other site metastases except ipsilateral humerus or sternum are present
With multiple metastatic lesions
Trial design
Treatments tested in this trial
- Radical resection
- Radical radiotherapy
- Palliative treatment
Treatment groups
Sponsors and collaborators
xuexin he
Lead sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Sponsor institution